Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate

European Journal of Dermatology

Volumn 20, Issue 4, 2010, Pages 511-512

  López Ferrer, Anna ^a   Puig, Luis ^a   Moreno, Gerardo ^b   Camps Fresneda, Alejandro ^b   Palou, José ^c   Alomar, Agustín ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b CENTRO MÉDICO TEKNON   (Spain)

^c Unitat de Dermatopatologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; PITYRIASIS LICHENOIDES; SKIN BIOPSY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; CHEMICALLY INDUCED; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PITYRIASIS LICHENOIDES;

EID: 77954725487     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0958     Document Type: Letter

References (6)

1. Roé E, Puig L, Corella F, García-Navarro X, Alomar A. Cutaneous adverse effects of biological therapies for psoriasis. Eur J Dermatol 2008; 18: 693-9.
2. Newell EL, Jain S, Stephens C, Martland G. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis. JEADV 2009; 23: 169-243.
3. Said BB, Kanitakis J, Graber I, Nicolas JF, Saurin JC, Berard F. Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: Report of 2 cases successfully treated with methotrexate. Inflamm Bowel Dis. 2009 Oct 9. [Epub ahead of print]
4. Tsianakas A, Hoeger PH. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha. Br J Dermatol 2005; 152: 794-9.
5. Nikkels AF, Gillard P, Piérard GE. Etanercept in therapy multiresistant overlapping pityriasis lichenoides. J Drugs Dermatol 2008; 7: 990-2.
6. Bremmer M, Deng A, Gaspari AA. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 2. Dermatitis 2009; 20: 243-56.